About Us

We are a leading digital health and AI (Artificial intelligence) company operating in the rare disease and genetic condition field.

Why FDNA Telehealth?

Accurate and precise: we have a 90% accuracy rate in detecting the correct phenotype with advanced AI capabilities and technology.
Credible and trustworthy: our facial recognition diagnostic technology is currently used by over 70% of geneticists, and has been used to help diagnose over 250,000 patients. FDNA has over 8 years of extensive experience in the research and development of diagnosing rare genetic disorders.
Accessible: facial analysis and screening in minutes, followed by fast access to genetic counsellors - within 48 hours if requested. Eliminate the wait for answers and prevent delays in your diagnostic journey.
Easy to use: as a virtual care platform FDNA Telehealth provides a seamless process that accompanies parents and families from initial diagnosis reports, to meetings with genetic counselors, to clinical consultations with geneticists and beyond.
Value for money: an advanced reference tool that grants access to genetic counsellors and geneticists fast.
Safe and secure: all data is stored in a secure cloud-based clinical warehouse, where it is integrated to LIMS, EMR and other systems through a set of open APIs.

Building AI-based Phenotyping Technologies

Genomic analysis is the new golden clinical standard in the field of diagnostics. This analysis combined with artificial intelligence technologies and deep learning is enabling us to understand more about the diagnosis and management of rare genetic syndromes than ever before.

We utilize FDNA’s next-generation phenotyping (NGP) technologies to sequence and analyze genomes in order to speed up the diagnostic odyssey of families seeking answers, and to provide families with the diagnosis they need, fast.

Our facial recognition software and analysis places families in control of their diagnostic journey and helping them move from misdiagnosed, or undiagnosed to diagnosed can make a world of difference in improving a child’s outcomes and quality of life

Used by 10,000+ hospitals and medical centers worldwide

Scientific Advisory Board

Since its founding in 2011, FDNA has continuously built an experienced and successful leadership team with 50+ doctors, genetic counselors, and other healthcare experts on our professional advisory board. Together, we aim to bring hope and find answers and treatments for hundreds-of-millions of patients globally living with a genetic disease.

Dr. Peter Krawitz, MD
Director of the Institute for Genomic Statistics and Bioinformatics, University of Bonn, Germany

Dr. Karen Gripp, MD, FAAP, FACMG
Chief of the Division of Medical Genetics, AI duPont Hospital for Children, Wilmington, DE

Dr. Karen Madden, Ph.D.
Vice President of Technology and Innovation, PerkinElmer, Inc.

Dr. Madhuri Hedge
PerkinElmer, Inc., Atlanta, GA, USA

Dr. David A. Chitayat, FABMG, FACMG, FCCMG, FRCPC
SickKids Hospital, Toronto, Canada

Prof. Jill Clayton-Smith, MB ChB, MRCP, FRCP
St Mary's Hospital, Manchester, England

Dr. Cynthia J.R. Curry
Genetic Medicine Central California, Fresno, CA, USA

Prof. Dian Donnai, CBE, FMedSci, FRCP
St Mary's Hospital, Manchester, England

Prof. Mordechai (Motti) Shochat, MD
Sheba Medical Center, Tel-Hashomer, Israel

Dr. Michael Baraitser
London Medical Databases, London, England

Vivian J. Weinblatt, MS, CGC
Arcadia University, Glenside, PA, USA

Prof. Dr. Gabriele Gillessen-Kaesbach, MD
Director, Institut für Humangenetik, Lubeck, Germany

Dr. Himanshu Goel, MBBS, DM, FRACP
University of Newcastle, Newcastle, Australia

Dr. Anna C. E. Hurst, MS
University of Alabama, Birmingham, AL, USA

Dr. Valeria Capra, MD
Istituto Giannina Gaslini, Genova, Italy

Dr. Annick Raas Rothschild
Sheba Medical Center, Tel-Hashomer, Israel

Dr. Chad Haldeman-Englert
Fullerton Genetics Center, Asheville, NC, USA

Prof. Koen Devriendt
University Hospitals Leuven, Belgium

Dr. Omar Abdul-Rahman
University of Nebraska Medical Center, Omaha, NE, USA

Dr. John Graham, ScD
CSMC and Harbor-UCLA Medical Center, Torrance, CA, USA

Prof. Martin Zenker, MD
Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany

Dr. Scott McLean
Children’s Hospital of San Antonio, San Antonio, TX, USA

Dr. Antonio Martinez Carrascal
Requena General Hospital, Valencia, Spain

Dr. Brian Chung
Queen Mary Hospital, Hong Kong

Dr. Carlos Ferreira, FACMG
Children's National Health System, Washington, D.C.

Dr. Elizabeth Roeder
Children's Hospital of San Antonio, San Antonio, TX, USA

Dr. Oana Moldovan
Centro Genética Médica St, Maria, Lisbon, Portugal

Dr. Lynne Bird
Rady Children’s Hospital, San Diego, CA, USA

Dr. Margaret Adam
University of Washington, Seattle, WA, USA

Dr. José Elías García-Ortiz
CIBO, Guadalajara, Mexico

Dr. Matt Deardorff
Children's Hospital of Philadelphia, PA, USA

Dr. Olaf Bodamer, PhD, FACMG, FAAP
Boston Children's Hospital, Boston, MA, USA

Prof. Alessandra Renieri
Università di Siena, Siena, Italy

Dr. Alan Beggs
Boston Children's Hospital, Boston, MA, USA

Dr. Pedro Sanchez
Children's Hospital of Los Angeles, Los Angeles, CA

Dr. Ronny Kershenovich S.
Hospital General de Mexico, Mexico City, Mexico

Dr. Steven A. Skinner
Greenwood Genetic Center, Greenwood, SC, USA

Dr. John Carey
University of Utah, Salt Lake City, UT, USA

Dr. Donald G. Basel
Children's Hospital of Wisconsin, Milwaukee, WI, USA

Dr. June Anne Gold
Loma Linda University Medical Center, Loma Linda, CA, USA

Dr. Ghayda Mirzaa
Seattle Children's Research Institute Center for Integrative Brain Research, Seattle, WA, USA

Prof. Alain Verloes
Hôpital Robert-Debré Ap-Hp, Paris, France

Dr. Andrea Superti-Furga
University of Lausanne, Lausanne, Switzerland

Dr. Arnold Munnich
Imagine Necker, France

Dr. Ben Solomon
GeneDx, Gaithersburg, MD, USA

Dr. Bill Dobyns
Seattle Children's Hospital, Seattle, WA, USA

Dr. Christina Fagerberg
Odense University Hospital, Odense, Denmark

Prof. Giovanni Neri
Istituto di Genetica Medica Universita Cattolica, Rome, Italy

Dr. Michael Hayden
Teva Pharmaceutical Industries, Petah Tikva, Israel

Dr. Miguel del Campo
Rady Children's Hospital, San Diego, CA, USA

Prof. Poh-San Lai
National University of Singapore, Singapore

Dr. Tinatin Tkemaladze
Tbilisi State Medical University, Tbilisi, Georgia

Over 400 million people are living with a rare disease globally, but most of them are misdiagnosed or paused within their diagnostic odyssey. Get a faster and more accurate analysis with FDNA Telehealth.